Tumore del colon-retto, ecco i farmaci che “affamano” il tumore e ne bloccano la crescita

Colorectal cancer is the third most common cancer in the world. Prevention and early diagnosis are crucial, as survival in the early stages of the disease is approximately 90%. Today, thanks to innovative therapies, even advanced or metastatic tumors can be treated. In addition to surgery and chemotherapy, targeted and specific drugs are available that improve overall survival and progression-free survival. And as confirmed by the ESMO journal, the European Society of Oncology, fruquintinib is effective in previously treated metastatic colorectal cancer because it blocks angiogenesis, the process by which a malignant tumor stimulates the formation of new blood vessels to nourish itself and grow. Read the full article on clipsalute.it In the video: ALBERTO PUCCINI Medical Oncologist, IRCCS Istituto Clinico Humanitas Cancer Center – Milan ANDREA SARTORE BIANCHI Medical Oncologist, ASST Grande Ospedale Metropolitano Niguarda – Milan